Gaurav Shah proposes selling 3,020 shares of Rocket Pharmaceuticals (RCKT).
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
Gaurav Shah, an officer and director of Rocket Pharmaceuticals (RCKT), has proposed selling 3,020 common shares valued at $6,795.91, with an approximate sale date of November 13, 2026. These shares were acquired through restricted stock vesting on November 11, 2026, as compensation, and the sale includes an amount to cover tax obligations from a vested equity award distribution.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.